HCV NS3 protease inhibitors
US8309540B2 · kind B2 · utility
1Cited by
8References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2007 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Apr 3, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.